title: Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.
authors.affiliation: Infectious Disease Section, New York Veterans Administration Medical Center, New York City.
authors.forename: B D
authors.initials: BD
authors.lastname: Agins
authors.forename: D S
authors.initials: DS
authors.lastname: Berman
authors.forename: D
authors.initials: D
authors.lastname: Spicehandler
authors.forename: W
authors.initials: W
authors.lastname: el-Sadr
authors.forename: M S
authors.initials: MS
authors.lastname: Simberkoff
authors.forename: J J
authors.initials: JJ
authors.lastname: Rahal
mesh_terms: D000386:AIDS-Related Complex / Q000150:complications*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002991:Clofazimine / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D047029:Lactams, Macrocyclic; D015269:Mycobacterium avium Complex / Q000187:drug effects; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy; D012189:Retrospective Studies; D018805:Sepsis / Q000150:complications / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D047029:Lactams, Macrocyclic; D004977:Ethambutol; D002991:Clofazimine; D007538:Isoniazid